The process of developing oversight and monitoring mechanisms for psychotropic medication use among children in foster care begins with establishing state-level consensus on what to monitor and how to define what is being monitored.

A subset of representatives from the six states involved in the Center for Health Care Strategies’ Psychotropic Medications Quality Improvement Collaborative (PMQIC), known as the Data Workgroup, engaged in this process over a period of 9 months, taking into account related national efforts and ultimately reaching a consensus on what indicators to track and their definitions. This webinar described the work and results of this process, which may help other states in their own efforts to determine key measures to track and how to define them. The efforts of the Data Workgroup may also help to foster national dialogue on the importance of common definitions and measures related to the use of psychotropic medications in children.


  • Christopher Bellonci, MD, Assistant Professor, Psychiatry Department, Tufts University School of Medicine, and Chair of the PMQIC Data Workgroup
  • Molly Finnerty, MD, Director of Evidence Based Services and Implementation Science, New York State Office of Mental Health, and member of the NCINQ measure development team


These resources provide supplemental information related to the webinar content and the work of the Data Workgroup.